Pediatric non-Hodgkin lymphoma

Thomas G. Gross, Amanda M. Termuhlen

Research output: Contribution to journalReview article

6 Scopus citations

Abstract

Non-Hodgkin lymphoma (NHL) accounts for 7% of cancer in children and adolescents in the United States, or approximately 1000 cases annually. NHL in the pediatric population differs from that observed in adult patients with respect to staging systems, histologic subtypes of disease, treatment, and outcomes. Although more than 90% of pediatric NHL is of high-grade histology, more than 80% of patients achieve long-term event-free survival with modern therapy. This review focuses on current treatments for pediatric NHL and some of the differences between NHL observed in pediatric and adult patients.

Original languageEnglish (US)
Pages (from-to)167-173
Number of pages7
JournalCurrent Hematologic Malignancy Reports
Volume3
Issue number3
DOIs
StatePublished - Jul 1 2008
Externally publishedYes

Fingerprint Dive into the research topics of 'Pediatric non-Hodgkin lymphoma'. Together they form a unique fingerprint.

  • Cite this